Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

ClinicalTrials.gov ID: NCT04892706

Public ClinicalTrials.gov record NCT04892706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel (0.3% Adapalene/2.5% BPO), in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.

Study identification

NCT ID
NCT04892706
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
686 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 99 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 10, 2021
Primary completion
Sep 27, 2022
Completion
Sep 27, 2022
Last update posted
Oct 29, 2025

2021 – 2022

United States locations

U.S. sites
34
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Bausch Site 134 Bryant Arkansas 72022
Bausch Site 118 Rogers Arkansas 72758
Bausch Site 110 Fremont California 94538
Bausch Site 101 Manhattan Beach California 90266
Bausch Site 106 San Diego California 92123
Bausch Site 112 San Diego California 92123
Bausch Site 128 San Diego California 92123
Bausch Site 105 Boynton Beach Florida 33437
Bausch Site 126 Clearwater Florida 33761
Bausch Site 135 North Miami Beach Florida 33162
Bausch Site 143 Sanford Florida 32771
Bausch Site 102 Tampa Florida 33607
Bausch Site 104 West Palm Beach Florida 33401
Bausch Site 122 West Palm Beach Florida 33406
Bausch Site 124 Newnan Georgia 30263
Bausch Site 127 Boise Idaho 83704
Bausch Site 129 Louisville Kentucky 40241
Bausch Site 139 Mandeville Louisiana 70448
Bausch Site 121 Metairie Louisiana 70006
Bausch Site 116 Rockville Maryland 20850
Bausch Site 103 Brighton Massachusetts 21350
Bausch Site 120 New Brighton Minnesota 55112
Bausch Site 108 Las Vegas Nevada 89148
Bausch Site 119 New York New York 10022
Bausch Site 133 New York New York 10075
Bausch Site 142 High Point North Carolina 27262
Bausch Site 109 Dublin Ohio 43016
Bausch Site 117 Oklahoma City Oklahoma 73112
Bausch Site 107 Gresham Oregon 97030
Bausch Site 114 Nashville Tennessee 37215
Bausch Site 111 Austin Texas 78759
Bausch Site 132 Houston Texas 77098
Bausch Site 123 Pflugerville Texas 78660
Bausch Site 137 Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04892706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04892706 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →